HomeAbout NRCHow We RegulateAdvisory ActivitiesAdvisory Committee on the Medical Uses of Isotopes

# ACMUI Membership

The membership of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) includes health care professionals from various disciplines. The ACMUI is composed of the following: a nuclear medicine physician; a nuclear cardiologist; a medical physicist in nuclear medicine unsealed byproduct material; a medical physicist in radiation therapy; a radiation safety officer; a nuclear pharmacist; two radiation oncologists; a patients' rights advocate; a Food and Drug Administration representative; an Agreement State representative; a health care administrator; and a diagnostic radiologist.

Membership in the ACMUI is gained through a formal nomination and selection process. To fill vacancies on the ACMUI, the U.S. Nuclear Regulatory Commission (NRC) publishes a notice in the *Federal Register* requesting nominations from interested parties. After receiving nominations, the NRC convenes a selection panel consisting of NRC staff and a non-NRC Federal employee. This non-NRC Federal employee is always a professional who specializes in the vacancy to be filled. The selection panel evaluates each nominee and sends a recommendation for appointment by the Director, Office of Nuclear Material Safety and Safeguards. The Director reviews the recommendation, consults with the Commission, and appoints the ACMUI member.

ACMUI members are appointed to four-year terms and, with approval from NRC, may elect to serve up to two consecutive terms, for a maximum term of eight years.

Members pictured from left to right, top to bottom: Mr. Richard Green, Mr. Michael D. O’Hara, Chair Christopher T. Hanson, Mr. Josh Mailman, Dr. John F. Angle, Ms. Melissa Martin, Dr. Harvey Wolkov, Ms. Megan Shober, Commissioner David A. Wright, Commissioner Annie Caputo, Dr. Hossein Jadvar, Dr. Andrew Einstein, Dr. Richard Harvey, Dr. Michael R. Folkert.

For additional information on ACMUI membership see the list of ACMUI Specialties and Functions and NUREG/BR-0309, "Serving on the Advisory Committee on the Medical Uses of Isotopes (ACMUI): A Member's Guide."

Select one of the following names for biographical information.
        - Chair:  Hossein Jadvar, M.D., Ph.D. , Nuclear Medicine Physician
        - Vice Chair:   Richard L. Green , Nuclear Pharmacist

**Members:**
        - Rebecca Allen , Health Care Administrator
        - Andrew Einstein M.D. , Nuclear Cardiologist
        - Dr. Joanna R. Fair, MD, Ph.D. , Diagnostic Radiologist
        - Michael R. Folkert, M.D., Ph.D. , Brachytherapy radiation Oncologist
        - Richard L. Green , Nuclear Pharmacist
        - Hossein Jadvar, M.D., Ph.D ., Nuclear Medicine Physician
        - Richard Harvey, Ph.D. , Radiation Safety Officer
        - Josh Mailman , Patients' Rights Advocate
        - Melissa C. Martin , Medical Physicist, Nuclear Medicine
        - Michael D. O'Hara, Ph.D. , Food and Drug Administration Representative
        - Zoubir Ouhib , Therapy Medical Physicist
        - Megan L. Shober , Agreement State Representative
        - Harvey B. Wolkov, M.D. , Radiation Oncologist

See Previous ACMUI members

**Rebecca Allen**

Rebecca Allen serves as the healthcare administrator representative on the ACMUI.  Ms. Allen was appointed to the ACMUI in May 2021.

Ms. Allen earned her Bachelor of University Studies from Morehead State University in 1996, and her Master of Science in Radiologic Science-Administration from Midwestern State University in 2002. She has also earned an Executive Leadership for Healthcare Professionals certificate from Cornell University in 2011.

Ms. Allen currently serves as the Assistant Vice President for Operations at the University of Cincinnati (UC) Health – Medical Center in Cincinnati, Ohio and serves as the Enterprise Director of Radiology at UC Health. As Enterprise Director of Radiology at UC Health, she is responsible for the primary leadership of all radiology services, including oversight of costs, regulatory compliance, and accreditation. She serves as the Senior Management Representative of the Radiation Safety Committee at UC Health.

Ms. Allen is also a part of the Board of Directors with the Association of Medical Imaging Management (AHRA) and is responsible for setting curriculum and structure for radiology administrators nationwide. She holds a Certified Radiology Administrator certificate with AHRA and was selected as Leader of the Quarter at UC Health. She also holds a certificate as a UC Health Performance Improvement Leader. Ms. Allen has extensive experience in improving radiology departments at multiple healthcare institutions. She has been involved with uses of radiation in the healing arts since 1997 and has served in healthcare leadership through various roles at multiple institutions. Ms. Allen has clinical service line oversight experience in diagnostic imaging, interventional radiology and cardiology, radiation oncology, perioperative services, pharmacy, respiratory, and laboratory.

**Andrew Einstein M.D.**

Dr. Einstein earned a Bachelor of Arts degree in Mathematics from Princeton University and his Medical Degree from the Mount Sinai School of Medicine of the City University of New York. While at Mount Sinai, he also earned a doctorate in the department of biomathematical sciences and a Master of Philosophy. Dr. Einstein also earned a Master of Science degree in patient-oriented research/biostatistics from Columbia’s Mailman School of Public Health. Dr. Einstein is board certified by the Certification Board of Nuclear Cardiology, the American Board of Internal Medicine, and the Certification Board of Cardiovascular Computed Tomography.

Dr. Einstein also currently serves as tenured Associate Professor of Medicine at the Columbia University, with a primary appointment is in medicine/cardiology and a secondary appointment in radiology. He also serves as a Victoria and Esther Aboodi Cardiology Researcher. His research centers on improving the use of imaging in cardiovascular medicine, with particular interests and current funded projects in radiation safety, machine learning, amyloidosis, COVID-19, global health, and device development.

Dr. Einstein currently serves as member of the boards of directors of the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) Cardiovascular Council and of the American Society of Nuclear Cardiology (ASNC). He also serves as the chair of the Academic Cardiology Section of the American College of Cardiology (ACC). Dr. Einstein recently received the SNMMI’s Hermann L. Blumgart Award for outstanding achievement in the field of nuclear cardiology and service to the Cardiovascular Council. He has also received the Ken Brown Award of the ASNC for the best editorial in the Journal of Nuclear Cardiology, and the ACC’s Douglas P. Zipes Distinguished Young Scientist Award.

Dr. Einstein has authored or co-authored over 200 papers and abstracts in journals such as the New England Journal of Medicine, Lancet, Circulation, and the Journal of the American Medical Association, among many other peer-reviewed scientific publications. He is a member of the editorial boards of Journals of the American College of Cardiology: Cardiovascular Imaging and the Journal of Nuclear Cardiology and has served as an associate editor of the Journal of Cardiovascular Computed Tomography. He has served as a member of study sections of the Center for Scientific Review, National Heart, Lung, and Blood Institute, and National Cancer Institute. He also serves as a member of the Congressionally chartered National Council on Radiation Protection and Measurements and served as a voting member of the Food and Drug Administration’s Medical Imaging Drugs Advisory Committee. Dr. Einstein has served as a mentor to over forty trainees at various stages ranging from high school to junior faculty.

**Dr. Joanna R. Fair, MD, Ph.D.**

Joanna R. Fair, MD, Ph.D, currently serves as Senior Associate Dean of Graduate Medical Education and Designated Institutional Official as well as Interim Executive Vice Chair in the Department of Radiology for the University of New Mexico School of Medicine.

In response to a solicitation in the *Federal Register*on September 11, 2023, for the diagnostic radiologist representative position on the Advisory Committee on the Medical Uses of Isotopes, the U.S. Nuclear Regulatory Commission (NRC) staff received two nominations.

Dr. Fair earned a Bachelor of Arts degree in chemistry from Rice University. She also earned a doctorate in chemical physics from the University of Colorado as a National Science Foundation Fellow. Dr. Fair earned her Medical Degree from Washington University School of Medicine in St. Louis, MO. She completed a diagnostic radiology residency at the University of New Mexico and a nuclear medicine residency at the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis, MO. Dr. Fair is board certified by the American Board of Radiology in Diagnostic Radiology and Nuclear Radiology, and by the American Board of Nuclear Medicine (ABNM) in Nuclear Medicine.

Dr. Fair currently serves as a Regents’ Professor of Radiology at the University of New Mexico School of Medicine. She also serves as the interim Executive Vice Chair of the Department of Radiology. Her areas of specialty include nuclear medicine and imaging, oncologic imaging, and positron emission tomography imaging. She has spoken regionally and nationally about nuclear medicine imaging and therapy, feedback, residency program expansions, and other educational topics.

Dr. Fair is a member of several professional societies including the Association of American Medical Colleges (AAMC), the American College of Radiology, the Alliance of Directors and Vice Chairs of Education in Radiology, the Association of University Radiologists, the North American Neuroendocrine Tumor Society, and the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Nationally, Dr. Fair is a past chair of the ABNM as well as the former president of the Southwestern Chapter of the SNMMI. She is currently the Chair of the Women in Nuclear Medicine Committee of the SNMMI; member of the AAMC's Advancing Holistic Principles Advisory Committee and Group on Resident Affairs Steering Committee; member of the SNMMl's Mars Shot Task Force; and a lifetime member of the ABNM's Board of Directors. She also previously served on the Board of Directors of the American Board of Medical Specialties.

In her previous role as Chief of Nuclear Medicine at UNM, Dr. Fair held a key leadership role in regulatory compliance, including serving as the Vice Chair of the Radiation Control Committee and Human Use Subcommittee member for 8 years, as well as reviewing cancer imaging and therapy protocols for the New Mexico Cancer Care Alliance Protocol Review and Monitoring Committee. Dr. Fair contributed to published national standards for 18F-NaF PET-CT imaging for the SNMMI as well for ventilation-perfusion scintigraphy as part of the American College of Radiology Committee on Practice Parameters and Technical Standards for Nuclear Medicine and Molecular Imaging. Dr. Fair began the Theranostics program at UNM, establishing 68Ga-DOTATATE imaging and 177Lu-DOTATATE therapy programs.

**Dr. Michael R. Folkert**

Dr. Folkert currently serves as the Vice Chair and Chief of Brachytherapy for Northwell Health Cancer Institute Radiation Medicine at the Center for Advanced Medicine, in Lake Success, NY. Dr. Folkert was appointed to the ACMUI in August 2023, as the Brachytherapy radiation oncology representative. His focus is education, training, and safety in the therapeutic applications of radioisotopes.

Dr. Folkert earned Bachelor of Science and a Master of Science degrees in Nuclear Engineering from Massachusetts Institute of Technology (MIT). He also earned a doctorate in Radiological Sciences from the Harvard-MIT Division of Health Sciences and Technology. Dr. Folkert earned his Medical Degree from Harvard Medical School. Dr. Folkert is board certified by the American Board of Radiology.

Dr. Folkert also serves as the co-director of the Genitourinary Malignancy Program at Northwell Health and as Associate Professor of Radiation Medicine at the Zucker School of Medicine at Hofstra/Northwell. In his role as Vice Chair and Chief of Brachytherapy at Northwell Health, he directs the therapeutic radiopharmaceutical and unsealed source program at all the institution’s sites throughout the New York state. Dr. Folkert has designed and run clinical trials in prostate, spine, liver, and esophageal cancers, and is a pioneer and world expert in intraoperative radiation therapy for spinal tumors. In addition, he has helped develop brachytherapy applicators for rectal and esophageal cancers and developed techniques for intraoperative CT-guided treatment of spine and liver cancers. His research includes novel tissue sparing techniques in prostate cancer, radiopharmaceutical therapies in multiple subsites, brachytherapy applications throughout the body, and stereotactic ablative radiation therapy and adaptive radiation therapy techniques.

Dr. Folkert has authored or co-authored over 80 papers in peer-reviewed scientific publications, published more than 10 textbook chapters for the medical or scientific community, and has presented more than 100 abstracts, posters, or exhibits at professional meetings. Dr. Folkert is a member of several professional societies including, the American Brachytherapy Society (ABS), the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Radiological Society of North America (RSNA), the American Society of Clinical Oncology (ASCO), the Connective Tissue Oncology Society (CTOS), and the American Radium Society (ARS). Dr. Folkert is a member of ASTRO’s radiopharmaceutical working group and the NRC committee and is one of the subcommittee chairs for the ABS Education Committee where he focuses on brachytherapy applications such as radiopharmaceuticals, liver microsphere brachytherapy, and other areas outside of the traditional focus on prostate and gynecologic brachytherapy. Dr. Folkert received the Program Director of the Year Award at UT Southwestern in 2021 and was selected as the 2016-2017 Association of Residents in Radiation Oncology’s Educator of the Year.

**Richard L. Green**

Richard L. Green serves as the Nuclear Pharmacist representative on the ACMUI. He was appointed to the ACMUI in May 2018, and Vice Chair of ACMUI in February 2024.

Mr. Green holds a bachelor’s degree in pharmacy from the University of Arizona in Tucson, Arizona and has been an Authorized Nuclear Pharmacist since 1988. In 1992, Mr. Green received his board certification in nuclear pharmacy by the Board of Pharmacy Specialties (BPS). He currently is a private consultant. From 2006 to 2023 he served as the Director of Radiopharmacy Practice at Cardinal Health Nuclear & Precision Health Solutions (hereafter referred to as Cardinal Health). Prior to that, Mr. Green served as the Program Manager and Senior Manager of Pharmacy Practice at Cardinal Health in Dublin Ohio, as the Pharmacy Manager and Radiation Safety Officer at Syncor International Corporation in Las Vegas, Nevada and as a Staff Pharmacist and Radiation Safety Officer for Syncor International Corporation in Phoenix, Arizona. Mr. Green has taught Radiopharmacy to pharmacists and pharmacy technicians as part of several university and company affiliated ANP and NPT certificate programs for over 30 years.

Mr. Green has served on the BPS Nuclear Pharmacy Specialty Council as a specialist member and as elected Chair. Mr. Green was named a Fellow of the American Pharmacist Association in 2018. In addition, he is an active member of the Society of Nuclear Medicine and Molecular Imaging, and the American Pharmacist Association. Lastly, Mr. Green has made numerous presentations, has had articles accepted for publication as well as five patents.

**Richard Harvey, Ph.D.**

Dr. Richard Harvey serves as the Radiation Safety Officer (RSO) on the ACMUI. Dr. Harvey was appointed to the ACMUI in July 2022.

Dr. Harvey earned his Bachelor of Science in Nuclear Medicine Technology from State University of New York at Buffalo, Master of Science in Health Physics from the State University of New York at Buffalo, and his DrPH in Radiological Health Environmental Health Sciences from the University of Michigan. He is also a Certified Health Physicist, Licensed Medical Physicist (NY), Certified Laser Safety Officer, and Certified Medical Laser Safety Officer.

Dr. Harvey currently serves as the Director of Radiation Safety and RSO at the Roswell Park Comprehensive Cancer Center, Buffalo NY where he is responsible for the radiation protection program for a broad scope license that performs commercial, clinical, and scientific research. These responsibilities include regulatory compliance for all federal and state regulations, radioactive material licensing, and implementation of radiation safety training for the institution.

Dr. Harvey also currently serves as a Research Assistant Professor at the University of Buffalo where he teaches radiation biology and participates on thesis and doctoral committees of graduate students.

**Hossein Jadvar, M.D., Ph.D.**

Hossein Jadvar, M.D., Ph.D., M.P.H., M.B.A., M.S.L., FACNM, FSNMMI, serves as the nuclear medicine physician representative on the ACMUI. Dr. Jadvar was appointed to the ACMUI in October 2019, Vice Chair in May 2022, and Chair of ACMUI in February 2024.

Dr. Jadvar received his Bachelor’s degree in chemical engineering from Iowa State University, Ames; a Master’s in biomedical engineering from University of Wisconsin, Madison; a Master’s in computer engineering and a Doctorate in bioengineering, both from the University of Michigan, Ann Arbor; a Medical Degree from the University of Chicago Pritzker School of Medicine; a Master’s degree in Public Health from Harvard University; an Executive Master’s in Business Administration and the Master’s in Studies of Law, both from the University of Southern California. He completed an internship in internal medicine at the University of California, San Francisco, followed by a residency in diagnostic radiology and nuclear medicine at Stanford University, and a clinical fellowship in positron emission tomography with the Harvard Medical School Joint Program in Nuclear Medicine. Dr. Jadvar has also completed executive educational certificate programs in clinical effectiveness at Harvard Medical School, and in leadership at the University of Pennsylvania (Wharton).

Dr. Jadvar currently serves as a tenured Professor of Radiology, Urology, and Biomedical Engineering at the University of Southern California (USC), Los Angeles, California. He is also a full member of the USC Norris Comprehensive Cancer Center.

Dr. Jadvar has authored more than 180 peer-reviewed journal articles, published 4 books, 40 book chapters, 9 U.S. and European patents, numerous conference abstracts and full articles, and has had more than 300 invited speaker presentations and visiting professorships at national and international venues and universities. He serves on the leadership editorial boards of the Journal of Nuclear Medicine (Associate Editor), European Journal of Nuclear Medicine and Molecular Imaging (Associate Editor), Radiology (Consultant to the Editor), Clinical Nuclear Medicine (Deputy Editor), and Theranostics (Associate Editor). His research interests include applications of PET in clinical outcome research and in translational molecular imaging research with particular interest in prostate cancer, theranostics, and radiopharmaceutical therapy.

Dr. Jadvar is the past president and fellow of both the American College of Nuclear Medicine (ACNM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Dr. Jadvar was a Visiting Associate Scientist in bioengineering at the California Institute of Technology (Caltech), in Pasadena, and has been a National Institutes of Health funded investigator. He currently serves on multiple NIH review panels (with one term as a charter member for MEDI study section). Dr. Jadvar also serves on the review panels for the Department of Defense Congressionally Directed Medical Research Programs-Prostate Cancer Research Program, the Department of Energy Office of Science, and the Imaging Technology and Informatics Program of the Cancer Prevention and Research Institute of Texas. Dr. Jadvar is a past recipient of the NIH Resident Research Award, SNMMI Mark Tetalman Young Investigator Award, the Western Regional SNMMI Distinguished Scientist Award, the Academy for Radiology and Biomedical Imaging Research Distinguished Investigator Award, the inaugural fellowship in the USC Center for Excellence in Research, the inaugural Prof. Ajit Padhy Award from the World Association of Radiopharmaceutical and Molecular Therapy, the SNMMI PET Center of Excellence Peter E. Valk, MD, Memorial Award, the Dr. R.D. Lee Oration Award from the Association of Nuclear Medicine Physicians of India, the Best Mentor Awards from both USC and the ACNM, and the Lifetime Achievement Award from the ACNM.

**Josh Mailman**

Josh Mailman serves as the Patients’ Rights Advocate representative on the ACMUI. Mr. Mailman was appointed to the ACMUI in July 2021.

Mr. Mailman is an internationally recognized advocate for neuroendocrine tumor patients as well as an advocate for nuclear medicine and molecular imaging. He is the inaugural chairman of the Society of Nuclear Medicine and Molecular Imaging’s Patient Advocacy Advisory Board and a member of the Education and Research Foundation for Nuclear Medicine and Molecular Imaging Board.

Mr. Mailman also serves as President of NorCal CarciNET Community, an organization established to help those with neuroendocrine tumors and carcinoids to share challenges and experiences, learn about prognoses and treatments, find information, and improve communications between the medical community, patients, and caregivers. Additionally, he serves as the co-chair of the Patient Advocate Steering Committee for the National Cancer Institute, where he has been privileged to work on both the Gastrointestinal Steering Committee and the Neuroendocrine Tumor Task. Mr. Mailman is also a member of the American Society of Clinical Oncology’s Research Committee.

Mr. Mailman has an MBA from the Anderson School of Management at UCLA and has been a technology entrepreneur for more than 30 years.

**Melissa C. Martin**

Melissa C. Martin serves as the nuclear medicine medical physicist representative on the ACMUI. She was appointed to the ACMUI in August 2018.

Ms. Martin holds a Bachelors of Science degree in Engineering Technology (Radiation and Nuclear) from Oklahoma State University and a Master's degree in Medical Physics from University of California, Los Angeles.  Ms. Martin is board certified by the American Board of Radiology in Radiological Physics and by the American Board of Medical Physics in Radiation Oncology Physics. 

She was appointed to her current position of Certified Medical Physicist and President at Therapy Physics, Inc., a medical physics consulting firm, in 1992. Prior to this appointment, Ms. Martin has served as the Assistant Radiological Physicist and Assistant Radiation Safety Officer (RSO) at the Hospital of the Good Samaritan in Los Angeles, CA; as the Radiological Physicist and RSO at Memorial Medical Center in Long Beach, CA; as Radiological Physicist at St. Joseph Hospital in Orange, CA; and as an adjunct professor at California State University in Long Beach, CA.

Ms. Martin has served in numerous leadership positions in medical professional organizations, including the AAPM (past President and Chairman of the Board), American College of Medical Physics (Chair), American College of Radiology (Chair of Government Relations Committee of Commission on Medical Physics), Conference of Radiation Control Program Directors (Chairman of AAPM Workshop at Annual Meetings), and the American Board of Radiology (Member of Part 2 Diagnostic Physics Committee and Oral Board Examiner for Diagnostic Imaging and Medical Nuclear Physics Exams).  Ms. Martin has also worked with the International Atomic Energy Agency, the California Radiological Society, the Radiological Society of North America and the Health Physics Society.  In addition, Ms. Martin has authored many peer-reviewed research articles and has given numerous presentations as an invited speaker.

**Michael D. O'Hara, Ph.D.**

Michael D. O'Hara, Ph.D., has served as the Food and Drug Administration (FDA) representative on the ACMUI since November 2014.

Dr. O'Hara earned his bachelor's degree in biology from D'Youville College in Buffalo, a master's degree in Natural Sciences from the State University of New York at Buffalo and a doctorate of philosphy in Biological Sciences from Wayne State University in Detroit. He completed a postdoctoral fellowship in the laboratory of Experimental Radiation Oncology at Thomas Jefferson University in Philadelphia.

He remained as a faculty member at Thomas Jefferson University Medical College in the Department of Radiation Oncology. He lead research efforts investigating the impact of chemical agents that modify the thermal response of normal and malignant tissues during thermal/radiotherapy and investigated bone marrow transplantation as a method to treat *osteogenesis imperfecta*. Dr. O'Hara regularly taught an undergraduate course in "Health Physics and Radiation Biology", lectured medical residents and was a member of the Institutional Animal Care and Use Committee.

Dr. O'Hara moved to Cordis / a Johnson and Johnson company to manage the firm's radiation therapy efforts involving radioactive endovascular stents and catheter-based radiation sources. He was promoted to a Johnson and Johnson Research Fellow and continued to assist Cordis and other Johnson and Johnson companies with radiation-based therapies.

He joined the Food and Drug Administration in 2004 in the Division of Biology in the Office of Science and Engineering Laboratories within the Center for Devices and Radiological Health. His activities included research studies involving Relative Biological effectiveness of ionizing radiation and the thermal / radiotherapeutic response of human tumor cells. He also served as the chairman of the Animal Care and Use Committee and has served as a member of the CDRH Radiology Standards Committee, the CDRH Radiofrequency Working Group, the Interagency Radiofrequency Working group and the Health and Human Services Radiation Biodosimetry Working Group. Dr. O'Hara served the Office of Device Evaluation and the Office of In Vitro Diagnostics as an Acting Branch Chief and later an Acting Deputy Division Director. He currently serves the Office of In Vitro Diagnostics and Radiological health as one of the Deputy Division Directors of the Division of Radiological Health. This division is responsible for the pre-market evaluation, post-market medical device reporting and compliance for all radiation emitting medical devices.

**Zoubir Ouhib**

Zoubir Ouhib serves as the Therapy Medical Physicist representative on the ACMUI. Mr. Ouhib was appointed to the ACMUI in April 2018.

Mr. Ouhib holds a Master's degree in Medical Physics from the University of Cincinnati in Cincinnati, Ohio and another Master's degree in Nuclear Engineering from Georgia Institute of Technology in Atlanta, Georgia. Mr. Ouhib received his board certification in radiation therapy by the American Board of Radiology in 1992.

Mr. Ouhib was appointed to his current position as Chief Medical Physicist at the Lynn Cancer Institute of the Boca Raton Community Hospital in 1998. Prior to that, Mr. Ouhib served as Director of Medical Physics at Elliot Hospital in Manchester, New Hampshire and as Medical Physicist at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.

Mr. Ouhib serves and has served, in numerous leadership positions. These organizations include the following: the American Association of Physicists in Medicine (AAPM) (Vice Chair of the AAPM Task Groups BTSC, TG244, TG-236, TG182, TG253 and Working Group on Brachytherapy), the American Brachytherapy Society (ABS) (Past Chair of the ABS Physics Committee, Chair of the ABS Patient Safety Committee, Chair of the ABS Quality of Management of Brachytherapy School, and Chair of the ABS Dosimetry and Clinical Practice Aspects of Skin Brachytherapy Working Group), the American College of Radiology, the American Society of Therapeutic Radiology and Oncology (ASTRO), and the European Society for Radiology and Oncology.

**Megan L. Shober**

Megan L. Shober serves as the Agreement State Representative on the ACMUI. Ms. Shober was appointed to the ACMUI in April 2018.

Since 2003, Ms. Shober has been working for the Wisconsin Department of Health Services in Madison, Wisconsin, where she is currently the Supervisor of the Agreement State program. Ms. Shober is a subject matter expert on the domestic production of molybdenum-99, accelerator production of actinium-225, and the regulatory oversight of fusion devices.

Ms. Shober has previously served on the executive board of the Organization of Agreement States (OAS), and she served as the Agreement State co-chair of the NRC-OAS working group to develop 10 CFR 35.1000 licensing guidance for the ViewRayTM System for Radiation Therapy. Ms. Shober is currently a member of the Conference of Radiation Control Program Directors (CRCPD) Committee E-47 working on fusion activities.

Ms. Shober holds a bachelor’s degree in Geology from the College of Wooster, in Ohio, and a master’s degree in Geophysics from the University of Wisconsin-Madison.

**Harvey B. Wolkov, M.D.**

Harvey B. Wolkov, M.D. serves as the gamma stereotactic radiosurgery Radiation Oncologist representative on the ACMUI. He was appointed to the ACMUI in April 2019.

Dr. Wolkov earned his Bachelor's degree in Microbiology and Master’s degree in BioNuclear Physics from Purdue University in Lafayette, Indiana, and his Medical degree from the Medical College of Ohio, in Toledo, Ohio. He completed his internship at the University of California, San Francisco Medical Center, and his residency at Stanford University Hospital and served as Chief Resident. He was board certified by the American Board of Radiology in Therapeutic Radiology in 1983.

Following completion of his residency, he was appointed to his current position as Radiation Oncologist at the Sutter Radiation Oncology Center in Sacramento, CA. He previously served as the Director of the Radiation Oncology Division of Radiological Associates of Sacramento Medical Group, the Medical Director of the Radiation Oncology Center at the Sutter Cancer Center, and as an Associate Clinical Professor of Radiology, Surgery, and Radiation Oncology at the University of California, Davis, School of Medicine.

Dr. Wolkov is an active member in numerous professional societies. He previously held leadership positions in many of them including: the American College of Radiology (ACR) as Chairman of the Radiation Oncology Committee on Standards and Accreditation and as an ACR Councilor; the American College of Radiation Oncology (ACRO), serving on the Board of Chancellors and as Co-Chair of the Standards Committee; and the American Society for Radiation Oncology (ASTRO) as a former member of the Board of Directors, former member of the Ethics Committee, and former Vice Chair of the Outcomes Research Committee. Dr. Wolkov is the past President of the California Radiological Society, the Northern California Radiation Oncology Society, and the Council of Affiliated Regional Radiation Oncology Societies.

His primary research interests are brain tumors, gamma knife radiosurgery, and innovative radiation modalities. Dr. Wolkov co-developed the first intraoperative radiation therapy program in the community hospital setting, co-developed the Gamma Knife Center at Sutter Cancer Center, and established the first Leksell Gamma Knife® IconTM unit in North America.

Page Last Reviewed/Updated Friday, May 3, 2024

Section Navigation

#### Navigation

          - ACMUI Membership
          - ACMUI Recommendations and Actions
          - ACMUI Subcommittees
          - ACMUI History
          - Contact Us
          - ACMUI Charter

#### Spotlight

#### Choose a Section

                - The Commission
                - License Renewal Generic Environmental Review
                - Job Openings
                - Palisades Restart
                - Environmental Justice 
                - Pilgrim Water Releases
                - Monticello Tritium Issue
                - International Strategy 2021-2025
                - Tribal Liaison Program
                - MAP-X
                - Transformation at the NRC - Updated
                - OIG Hotline
                - Rulemaking Activity
                - Commission Documents
                - Advanced Reactors
                - Nuclear Security
                - Strategic Plan

Page Last Reviewed/Updated Friday, May 3, 2024